Summary: Evaluated Enhanced External Counterpulsation (EECP) versus placebo EECP (at non-therapeutic pressures). The primary endpoint of angina and time to 1 mm ST depression on a treadmill ECG test was reduced with EECP. There was no adverse events. No benefit in exercise tolerance or nitroglycerine use was seen.

Original Publication:

N Engl J Med 2006; 354:1706-1717

Eponym: MUlticenter STudy of Enhanced External CounterPulsation (EECP)